Ireland 'well placed' for future pharma innovation

Speaking at an event where pharmaceutical giant Pfizer was given IDA’s Special Recognition Award, Mr Lohan said he did not have any concerns for future foreign direct investment
Ireland 'well placed' for future pharma innovation

Albert Bourla, chief executive of Pfizer, with Michael Lohan, chief executive at IDA Ireland. Picture: Maxwells

IDA Ireland chief executive Michael Lohan has said the country is “well placed” to capitalise on future innovation in the medical sciences sector despite pharmaceutical companies seeing a contraction along with declining exports.

Data published last week showed that Ireland’s economy shrank by 1.9% between July and September, largely driven by falls in sectors dominated by multinationals. The industry sector, which includes pharmaceutical companies, declined by 3.5% with exports also dropping 2.1%.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited